You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京新百(600682.SH)子公司擬1300萬美元購買國際臍帶血庫企業集團部分股權
格隆匯 05-22 16:39

格隆匯5月22日丨南京新百(600682.SH)發佈公吿,公司子公司Dendreon Pharmaceuticals LLC(以下簡稱 Dendreon)擬以1300萬美元購買AMC Fund,L.P.(以下簡稱AMC Fund)持有的Global Cord Blood Corporation(以下簡稱CO集團或國際臍帶血庫)的200萬股股份。

本次交易前,南京新百持有南京盈鵬蕙康醫療產業投資合夥企業(有限合夥)(以下簡稱盈鵬蕙康)6.09%的財產份額,盈鵬蕙康持有上海藍海科瑞金融信息服務合夥企業(有限合夥)(以下簡稱藍海科瑞)99.64799%的財產份額,藍海科瑞通過其全資子公司Blue Ocean Structure Investment Company Ltd持有國際臍帶血庫65.43%股權。

本次交易公司子公司Dendreon 擬以現金支付1300萬美元的方式購買AMC Fund持有的國際臍帶血庫的200萬股股份,佔國際臍帶血庫總股份數的1.65%。本次交易後,南京新百將直接持有國際臍帶血庫1.65%的股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account